SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-23-045080
Filing Date
2023-08-29
Accepted
2023-08-29 16:30:39
Documents
2
Period of Report
2023-08-28

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1562
2 EX-24 omga-ex24.htm EX-24 17856
  Complete submission text file 0000950170-23-045080.txt   20789
Mailing Address 140 FIRST STREET, SUITE 501 CAMBRIDGE MA 02141
Business Address 140 FIRST STREET, SUITE 501 CAMBRIDGE MA 02141 (617) 949-4360
Omega Therapeutics, Inc. (Issuer) CIK: 0001850838 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O OMEGA THERAPEUTICS, INC. 20 ACORN PARK D CAMBRIDGE MA 02140
Business Address
Werner Michelle C (Reporting) CIK: 0001991154 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40657 | Film No.: 231222313